Dr. Dacey is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
11960 Lioness Way
Ste 290
Parker, CO 80134Phone+1 303-261-1600Fax+1 303-261-1601
Education & Training
University of Texas Southwestern Medical CenterResidency, Ophthalmology, 2006 - 2009
Texas Health Resources (Dallas)Internship, Internal Medicine, 2005 - 2006
University of Michigan Medical SchoolClass of 2005
Certifications & Licensure
CO State Medical License 2010 - 2025
SD State Medical License Active through 2019
MA State Medical License 2009 - 2012- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012-2013
Clinical Trials
- A Clinical Study to Evaluate the Potential Role of ACTH Gel in Patients With Scleritis Start of enrollment: 2019 Jan 01
Publications & Presentations
PubMed
- 1 citationsFilgotinib in Active Noninfectious Uveitis: The HUMBOLDT Randomized Clinical Trial.Sunil K Srivastava, Timothy R Watkins, Quan Dong Nguyen, Sumit Sharma, David K Scales
JAMA Ophthalmology. 2024-09-01 - 46 citationsBilateral uveitis associated with fluoroquinolone therapy.David M. Hinkle, Mark S. Dacey, Efrem D. Mandelcorn, Partho S. Kalyani, John Mauro
Cutaneous and Ocular Toxicology. 2012-05-16 - 74 citationsPanuveitis following Vaccination for COVID-19.Lucy I. Mudie, Jon D. Zick, Mark S. Dacey, Alan G. Palestine
Ocular Immunology and Inflammation. 2021-07-02
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
